Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Current Leases (2019 - 2026)

Viking Therapeutics' (VKTX) quarterly Current Leases came in at $161000.0 in Q2 2026, down 65.6% year-over-year from $468000.0 in Q2 2025, and up 17.52% quarter-over-quarter from $137000.0 in Q4 2025.

Analysis

Viking Therapeutics (VKTX) Current Leases (2019 - 2026) Analysis & Trends

Viking Therapeutics has disclosed Current Leases across 8 years of filings, most recently posting $161000.0 for Q2 2026.

  • In Q2 2026, Current Leases fell 65.6% year-over-year to $161000.0; the TTM figure through Jun 2026 stood at $161000.0 (down 65.6% YoY), while the FY2025 annual figure was $137000.0, down 71.98% from the prior year.
  • Current Leases came in at $161000.0 for Q2 2026 at Viking Therapeutics, up from $137000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $498000.0 in Q1 2025 to a low of $137000.0 in Q4 2025.
  • Average Current Leases over 5 years is $328823.5, with a median of $319000.0 recorded in 2023.
  • Year-over-year, Current Leases surged 948.28% in 2022 and sank 71.98% in 2025.
  • Over 5 years, Current Leases stood at $304000.0 in 2022, then grew by 6.58% to $324000.0 in 2023, then surged by 50.93% to $489000.0 in 2024, then slumped by 71.98% to $137000.0 in 2025, then gained by 17.52% to $161000.0 in 2026.
  • Per Business Quant data, the three most recent Current Leases figures were $161000.0 in Q2 2026, $137000.0 in Q4 2025, and $437000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -2.32 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 Viking Therapeutics 4.86 Bn 4.86 Bn - 161,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 161,000.00
Dec 31, 2025 137,000.00
Sep 30, 2025 437,000.00
Jun 30, 2025 468,000.00
Mar 31, 2025 498,000.00
Dec 31, 2024 489,000.00
Sep 30, 2024 480,000.00
Jun 30, 2024 334,000.00
Mar 31, 2024 329,000.00
Dec 31, 2023 324,000.00
Sep 30, 2023 319,000.00
Jun 30, 2023 314,000.00
Mar 31, 2023 309,000.00
Dec 31, 2022 304,000.00
Sep 30, 2022 299,000.00
Jun 30, 2022 238,000.00
Mar 31, 2022 150,000.00
Dec 31, 2021 29,000.00
Sep 30, 2021 115,000.00
Jun 30, 2021 198,000.00
API Access

Viking Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=VKTX&period=max&api_key=YOUR_API_KEY